FDCDDQ
ALGS icon

Federation des caisses Desjardins du Quebec’s Aligos Therapeutics ALGS Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.8K Buy
4,650
+3,700
+389% +$22.9K ﹤0.01% 2106
2026
Q1 		$7.06K Buy
+950
New +$7.21K ﹤0.01% 2415

Other funds holding ALGS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ALGS Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Aligos Therapeutics (ALGS) stake by 389% in Q2 2026, buying an estimated $22.9K and bringing the position to 4,650 shares worth $26.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

Federation des caisses Desjardins du Quebec first reported a position in ALGS in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold ALGS as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 4,650 shares of Aligos Therapeutics worth $26.8K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 3,700 Aligos Therapeutics shares in Q2 2026, an estimated $22.9K.
  • Aligos Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2106 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Aligos Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.